SEC Form 4 · accession 0000899243-17-027319
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tuesday Thirteen Inc.
10% Owner
Period of report
Sep 21, 2017
Accepted (ET)
Nov 22, 2017 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 21, 2017 | S | 1,000 | $10.65 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned directly by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc.